submit to the journals

EASD Highlights

flipper_slider

Editor's Choice

Professor Lauritsen gives more insight into her abstracts, posters and presentations, and data on clinical trials she had lead at this year’s EASD conference. Questions: 1. Please tell us about your presentation...

EASD Highlights Videos

Behind insulin resistance: debugging the endocrine system. How to tackle leptin deficiency in lipodystrophies. Speaker's disclosures: Julia von Schnurbein received speaker’s fees from Aegerion, and she is a consultant to Rhythm Pharmaceuticals. Elif Oral is a consultant to Aegerion...
Professor Stumvoll discusses his "Meet the Expert" session focussing on two patients with partial lipodystrophy. Speaker's disclosures: Speaker fees from Aegerion. This video is intended for health care professionals. Information for patients and carers can be found here Product...
Julia von Schnurbein discusses the latest advances in Myalepta and patients with lipodystrophies in Europe. Questions: 1. How can diabetologists recognise patients with lipodystrophies and Myalepta? (0:12) 2. What will it mean for patients with lipodystrophy that Myalepta is now available in...
Professor Oral summarises her key take home messages from her Aegerion-sponsored satellite symposium. Speaker's disclosures: Professor Oral is a consultant to Aegerion Pharmaceuticals with approved fee, has carried out research and consulting work for Akcea Therapeutics/Ionis Pharmaceuticals,...
Dr Giovanni Ceccarini discusses the key take-home messages from his Aegerion-sponsored Meet the Experts session at EASD 2018, where he focused on studies and therapeutics for patients with generalised lipodystrophy, and the effect of leptin and leptin-based treatment. Speaker's disclosures: Dr...
Mahmood Kazemi discusses the economic burden of insulin therapy and the benefits of flash glucose monitoring and routine self-monitoring of blood glucose. Questions: 1. Which glucose monitoring methods do the UK NHS guidelines currently recommend for adults with type 2 diabetes (T2D)? (0:11) 2...
Professor Holst discusses his current research and the most important current findings in diabetes. Questions 1. In today’s post-genomic era, are there any major endocrine hormones similar to GLP-1 left to discover? (0:12) 2. Will ‘diet pills’ will ever be able to outperform lifestyle...
Professor Rutten gives his perspective on the latest developments in safe de-intensification in the elderly. Questions 1. What are the latest developments in safe de-intensification in the elderly? (0:12) 2. What is your current research focus? (2:06) 3. What have been your highlights of EASD...
Dr Raza discusses the current status of aspirin use and the latest clinical trial data. Questions: 1. What is the historic importance of aspirin use? (0:12) 2. What are the current practices and guidelines for aspirin use? (1:00) 3. What recent data have been presented in aspirin use? (1:50...
Professor Danne explores recent developments in paediatric diabetes. Questions: 1. What are the latest advances in paediatric diabetes care? (0:12) 2. What are the current developments in new insulins, glucose sensors and insulin pumps? (0:50) 3. What are your highlights of EASD 2018 so far,...
Professor Lauritsen gives more insight into her abstracts, posters and presentations, and data on clinical trials she had lead at this year’s EASD conference. Questions: 1. Please tell us about your presentation at this year’s EASD conference? (0:12) 2. What are the most important current...
Professor Home discusses the latest insights gained from recent clinical trials and looks to the future of glucose lowering medications. Questions: 1. What are the most exciting advances in clinical diabetes at EASD 2018? (0:12) 2. What clinical trial data on glucose-lowering medications are...
Professor Reja discusses the challenges resulting from the recent rise in type 2 diabetes in Ethiopia, and how the Ministers of Health are supporting patient care. Questions: 1. What is the current state of diabetes in Ethiopia? (0:12) 2. What are the main challenges for diabetes patients in...
Dr Somasundaram gives a South Asian perspective on the latest advances in sleep disruption and circadian rhythm. Questions: 1. What is the relationship between circadian rhythm and sleep disruption? (0:12) 2. What are the latest advances and countermeasures in the disruption of circadian...
Dr Saboo discusses the latest research developments in the management of diabetes in India and provides an overview of BLUE INDEX. Questions: 1. What is India's contribution to endocrinology and diabetes conferences? (0:12) 2. What are the latest developments in type 1 diabetes care? (1:29)...